Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, December 3 2009 2:05am ET - U.S. Markets open in 7 hours and 25 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Biotechnology News
View: Latest News | Top Stories
Thursday, Nov 5, 2009
·MDRNA, Inc. to Hold Third Quarter 2009 Results Conference Call on Thursday, November 12, 2009 at 4:30 pm Eastern Time
Marketwire - Thu Nov 5
·GenVec Signs New Contract to Support HIV and Influenza Vaccine Development
PR Newswire - Thu Nov 5
·Hemispherx Biopharma Could Become a Nice Rebound Story
at Seeking Alpha - Thu Nov 5
·ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
Business Wire - Thu Nov 5
·Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides Pipeline Update
Business Wire - Thu Nov 5
·VIVUS To Present at Merriman Curhan Ford's Investor Summit
PR Newswire - Thu Nov 5
·BioCryst Receives First Peramivir Order From U.S. Government
PR Newswire - Thu Nov 5
·Micromet, Inc. Reports Third Quarter 2009 Financial Results
GlobeNewswire - Thu Nov 5
·Compugen Announces Preeclampsia Biomarker Collaboration
Business Wire - Thu Nov 5
·Eurand Reports Key Achievements and Strong Revenue Growth for Third Quarter 2009
Marketwire - Thu Nov 5
·Incyte Reports Third Quarter 2009 Financial Results and Provides Update on Drug Development Programs
Business Wire - Thu Nov 5
·Repligen Reports Second Quarter Fiscal Year 2010 Financial Results
PR Newswire - Thu Nov 5
·Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting
Business Wire - Thu Nov 5
·Micromet Buys Out MedImmune's Remaining Rights to Blinatumomab
GlobeNewswire - Thu Nov 5
·QIAGEN and British Veterinary Laboratories Agency Expand Partnership in Veterinary Testing
Business Wire - Thu Nov 5
·Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45%
PR Newswire - Thu Nov 5
Wednesday, Nov 4, 2009
·The Return of Immunogen?
at CNBC - Wed Nov 4
·Sangamo Biosciences, Inc. Q3 2009 Earnings Call Transcript
at Seeking Alpha - Wed Nov 4
·Abraxis Health Dedicates State of the Art Nanotechnology & Biologics Facility in Phoenix, Arizona
Business Wire - Wed Nov 4
·Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
PR Newswire - Wed Nov 4
More Latest News...
Sponsor Results
Hemispherx Biopharma, Inc. (HEB)
Kaplan Fox Investigates Possible Securities Fraud at Hemispherx
www.kaplanfox.com
Live Forex Practice Account
Practice Forex Trading in Real Market Conditions with a Free Trial.
www.GFTforex.com
Earn From 1.90% to 2.20% Apply Online
With GE Capital Corporation. Not An Offer Of Securities For Sale.
www.geinterestplus.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Biotechnology Headlines
More Finance RSS Feeds


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?